DK603588D0 - TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION - Google Patents

TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION

Info

Publication number: DK603588D0
Authority: DK; Denmark
Prior art keywords: furo; thieno; tetrahydro; pyridine; medicine
Prior art date: 1987-10-29

Application number

DK603588A

Other languages

Danish (da)

Other versions

DK603588A (en

Inventor

Albrechs Harreus

Karl-Heinz Weber

Gerhard Walther

Werner Stransky

Franz Josef Kuhn

Guenter Schingnitz

Helmut Ensinger

Original Assignee

Boehringer Ingelheim Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-10-29

Filing date

1988-10-28

Publication date

1988-10-28

1988-10-28 Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg

1988-10-28 Publication of DK603588D0 publication Critical patent/DK603588D0/en

1989-04-30 Publication of DK603588A publication Critical patent/DK603588A/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK603588A 1987-10-29 1988-10-28 TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION DK603588A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19873736664 DE3736664A1 (en)	1987-10-29	1987-10-29	TETRAHYDRO-FURO- AND -THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICAMENT AND METHOD FOR THE PRODUCTION THEREOF

Publications (2)

Publication Number	Publication Date
DK603588D0 true DK603588D0 (en)	1988-10-28
DK603588A DK603588A (en)	1989-04-30

Family

ID=6339349

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK603588A DK603588A (en)	1987-10-29	1988-10-28	TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION

Country Status (17)

Country	Link
EP (1)	EP0314154A3 (en)
JP (1)	JPH01157983A (en)
KR (1)	KR890006650A (en)
AU (1)	AU2443588A (en)
CS (1)	CS273193B2 (en)
DD (1)	DD283395A5 (en)
DE (1)	DE3736664A1 (en)
DK (1)	DK603588A (en)
FI (1)	FI884947A7 (en)
HU (1)	HU201553B (en)
IL (1)	IL88184A0 (en)
NO (1)	NO884835L (en)
PL (1)	PL275555A1 (en)
PT (1)	PT88899B (en)
SU (1)	SU1657064A3 (en)
YU (1)	YU201288A (en)
ZA (1)	ZA888089B (en)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2623810B2 (en) *	1987-02-17	1992-01-24	Sanofi Sa	ALPHA SALTS- (TETRAHYDRO-4,5,6,7 THIENO (3,2-C) PYRIDYL-5) (2-CHLORO-PHENYL) -THETHYL ACETATE DEXTROGYRE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
US5272148A (en) *	1992-09-09	1993-12-21	Hoechst-Roussel Pharmaceuticals Incorporated	Heteroarenylpiperazines
US8914114B2 (en)	2000-05-23	2014-12-16	The Feinstein Institute For Medical Research	Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
EP1728794B1 (en) *	2000-07-06	2008-06-18	Daiichi Sankyo Company, Limited	Maleate addition salt of hydropyridine derivatives
AU2003217747A1 (en) *	2002-02-26	2003-09-09	North Shore-Long Island Jewish Research Insitute	Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
AU2005225458B2 (en)	2004-03-25	2008-12-04	The Feinstein Institutes For Medical Research	Neural tourniquet
US10912712B2 (en)	2004-03-25	2021-02-09	The Feinstein Institutes For Medical Research	Treatment of bleeding by non-invasive stimulation
US11207518B2 (en)	2004-12-27	2021-12-28	The Feinstein Institutes For Medical Research	Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
DE602005025020D1 (en)	2004-12-27	2011-01-05	The Feinstein Inst Medical Res	TREATMENT OF INFLAMMATORY DISEASES BY EL
TWI392681B (en) *	2006-04-06	2013-04-11	Daiichi Sankyo Co Ltd	Prasugrel with high purity and a method for preparing its acid addition salt
AU2008222000B2 (en) *	2007-03-02	2012-06-14	Daiichi Sankyo Company, Limited	Process for production of prasugrel hydrochloride having high purity
WO2009029614A1 (en)	2007-08-27	2009-03-05	The Feinstein Institute For Medical Research	Devices and methods for inhibiting granulocyte activation by neural stimulation
US9211409B2 (en)	2008-03-31	2015-12-15	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation of T-cell activity
US9662490B2 (en)	2008-03-31	2017-05-30	The Feinstein Institute For Medical Research	Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
US9211410B2 (en)	2009-05-01	2015-12-15	Setpoint Medical Corporation	Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US8996116B2 (en)	2009-10-30	2015-03-31	Setpoint Medical Corporation	Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
EP2440284B1 (en)	2009-06-09	2018-09-12	Setpoint Medical Corporation	Nerve cuff with pocket for leadless stimulator
WO2014169145A1 (en)	2013-04-10	2014-10-16	Setpoint Medical Corporation	Closed-loop vagus nerve stimulation
US9833621B2 (en)	2011-09-23	2017-12-05	Setpoint Medical Corporation	Modulation of sirtuins by vagus nerve stimulation
WO2011079309A2 (en)	2009-12-23	2011-06-30	Setpoint Medical Corporation	Neural stimulation devices and systems for treatment of chronic inflammation
US12172017B2 (en)	2011-05-09	2024-12-24	Setpoint Medical Corporation	Vagus nerve stimulation to treat neurodegenerative disorders
WO2012154865A2 (en)	2011-05-09	2012-11-15	Setpoint Medical Corporation	Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US9572983B2 (en)	2012-03-26	2017-02-21	Setpoint Medical Corporation	Devices and methods for modulation of bone erosion
US11311725B2 (en)	2014-10-24	2022-04-26	Setpoint Medical Corporation	Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en)	2015-02-03	2016-08-11	Setpoint Medical Corporation	Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en)	2016-01-13	2020-03-24	Setpoint Medical Corporation	Systems and methods for establishing a nerve block
EP3405255B1 (en)	2016-01-20	2025-12-31	Setpoint Medical Corporation	IMPLANTABLE MICROSIMULATORS AND INDUCTIVE CHARGING SYSTEMS
WO2017127756A1 (en)	2016-01-20	2017-07-27	Setpoint Medical Corporation	Control of vagal stimulation
US11471681B2 (en)	2016-01-20	2022-10-18	Setpoint Medical Corporation	Batteryless implantable microstimulators
US10583304B2 (en)	2016-01-25	2020-03-10	Setpoint Medical Corporation	Implantable neurostimulator having power control and thermal regulation and methods of use
WO2019036470A1 (en)	2017-08-14	2019-02-21	Setpoint Medical Corporation	Vagus nerve stimulation pre-screening test
US11260229B2 (en)	2018-09-25	2022-03-01	The Feinstein Institutes For Medical Research	Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
CN113939334A (en)	2019-04-12	2022-01-14	赛博恩特医疗器械公司	Treatment of neurodegenerative disorders by vagal nerve stimulation
EP4566539A1 (en)	2020-05-21	2025-06-11	The Feinstein Institutes for Medical Research	Systems and methods for vagus nerve stimulation
WO2022245878A1 (en)	2021-05-17	2022-11-24	Setpoint Medical Corporation	Neurostimulation parameter authentication and expiration system for neurostimulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2315274A1 (en) *	1975-06-27	1977-01-21	Parcor	NEW DERIVATIVES OF THIENO (2,3-C) PYRIDINE, THEIR PREPARATION AND THEIR APPLICATIONS
FR2317303A1 (en) *	1975-07-09	1977-02-04	Parcor	PROCESS FOR PREPARING TETRAHYDROTHIENO (3,2-C) AND (2,3-C) PYRIDINE DERIVATIVES

1987
- 1987-10-29 DE DE19873736664 patent/DE3736664A1/en not_active Withdrawn
1988
- 1988-10-27 CS CS712688A patent/CS273193B2/en unknown
- 1988-10-27 FI FI884947A patent/FI884947A7/en not_active IP Right Cessation
- 1988-10-27 YU YU02012/88A patent/YU201288A/en unknown
- 1988-10-27 IL IL88184A patent/IL88184A0/en unknown
- 1988-10-27 DD DD88321141A patent/DD283395A5/en not_active IP Right Cessation
- 1988-10-28 KR KR1019880014063A patent/KR890006650A/en not_active Withdrawn
- 1988-10-28 NO NO88884835A patent/NO884835L/en unknown
- 1988-10-28 HU HU885642A patent/HU201553B/en not_active IP Right Cessation
- 1988-10-28 PT PT88899A patent/PT88899B/en not_active IP Right Cessation
- 1988-10-28 AU AU24435/88A patent/AU2443588A/en not_active Abandoned
- 1988-10-28 EP EP19880117961 patent/EP0314154A3/en not_active Withdrawn
- 1988-10-28 SU SU884356747A patent/SU1657064A3/en active
- 1988-10-28 ZA ZA888089A patent/ZA888089B/en unknown
- 1988-10-28 PL PL27555588A patent/PL275555A1/en unknown
- 1988-10-28 DK DK603588A patent/DK603588A/en not_active Application Discontinuation
- 1988-10-28 JP JP63272853A patent/JPH01157983A/en active Pending

Also Published As

Publication number	Publication date
IL88184A0 (en)	1989-06-30
FI884947L (en)	1989-04-30
YU201288A (en)	1990-08-31
HU201553B (en)	1990-11-28
PT88899B (en)	1993-01-29
KR890006650A (en)	1989-06-15
SU1657064A3 (en)	1991-06-15
CS712688A2 (en)	1990-06-13
NO884835L (en)	1989-05-02
CS273193B2 (en)	1991-03-12
DK603588A (en)	1989-04-30
DD283395A5 (en)	1990-10-10
EP0314154A2 (en)	1989-05-03
HUT50824A (en)	1990-03-28
JPH01157983A (en)	1989-06-21
FI884947A7 (en)	1989-04-30
NO884835D0 (en)	1988-10-28
ZA888089B (en)	1990-07-25
AU2443588A (en)	1989-07-13
PL275555A1 (en)	1989-05-02
EP0314154A3 (en)	1990-12-05
FI884947A0 (en)	1988-10-27
DE3736664A1 (en)	1989-05-11

Publication	Publication Date	Title
DK603588D0 (en)	1988-10-28	TETRAHYDRO-FURO- AND THIENO (2,3-C) PYRIDINE, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION
DK132789D0 (en)	1989-03-17	9-HALOGEN (Z) PROSTAGLAND INGREDIENTS, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS A MEDICINE
DK584089A (en)	1990-05-23	QUINUCLIDINES, THEIR USE AS A MEDICINE AND PROCEDURE FOR THEIR PREPARATION
DK143588D0 (en)	1988-03-16	SUBSTITUTED 9-AMINO-TETRAHYDROACRIDINES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK381985A (en)	1986-02-24	3-PYRIDYL COMPOUNDS, THEIR PREPARATION AND USE AS A MEDICINE
DK660788A (en)	1989-05-28	2,2-DIFLUOROCYCLOPROPYLETHER DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES
DK435588A (en)	1989-02-08	ARALKYLAMINOAL COXYPHENYL DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND MENTALS CONTAINING THESE
DK304090D0 (en)	1990-12-21	GLYCEROLD DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THERAPEUTIC PREPARATIONS CONTAINING THESE
DK619286A (en)	1987-06-22	PYRIDINE DERIVATIVES AND N-OXIDES THEREOF, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS INTERMEDIATES
DK0427526T3 (en)	1994-08-29	Pyridine derivatives, processes for their preparation and pharmaceutical compositions containing them
DK0387568T3 (en)	1995-01-23	Substituted 1,8-naphthyridines, methods for their preparation and their use as antidotes
DK495984D0 (en)	1984-10-17	1,3-DIHYDRO-6-METHYL-7-HYDROXYFURO- (3,4-C) PYRIDINE DERIVATIVE, PROCEDURES FOR PREPARING THEREOF, AND PHARMACEUTICAL PREPARATION CONTAINING SUCH A CONNECTION
DK247787D0 (en)	1987-05-14	PYRAZOL (3,4-B) PYRIDINE DERIVATIVES, PROCEDURES AND INTERMEDIATES FOR PREPARING THEREOF AND USING ITS AS HERBICIDE EFFECTS
FI883668A7 (en)	1989-02-08	2-methyl(4-piperidinyl)benzofuro/2,3-c/pyridine derivatives, their preparation and therapeutic use
DK501888A (en)	1989-03-12	6-MERCAPTOPURIN DERIVATIVES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK132386A (en)	1986-09-23	5H-PYRIDO (3 ', 4'.4,5) PYRROLO (3,2-C) PYRIDINE DERIVATIVES AND PROCEDURES FOR PREPARING THEREOF
DK613486D0 (en)	1986-12-18	1-H-PYRIDO- (3,2-B) (1,4) -THIAZINES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DK87787D0 (en)	1987-02-20	PYRROLO (3,4-B) PYRIDINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND MEDICINALS CONTAINING THEM
DK364589A (en)	1990-01-26	PYRIDO (3,4-F) PYRROLO (1,2-B) (1,2,5) -TRIAZEPINES, THEIR PREPARATION AND USE AS MEDICINAL PRODUCTS
DK454588A (en)	1989-02-16	SUBSTITUTED THIENOIMIDAZOLE DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS THEREOF AND THEIR USE AS ANTI-MACHINE ACID PROCEDURES
DK288685A (en)	1985-12-28	4,5,6,7-TETRAHYDRO-FURO- OR 1H-PYRROLO (2,3-C) PYRIDINE DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND MEDICINALS CONTAINING SUCH DERIVATIVES
DK276690D0 (en)	1990-11-21	Selenium-derived derivatives, methods for their preparation and therapeutic preparations containing these
DK144787D0 (en)	1987-03-20	PYRIDO (4,3-B) (1,6) NAPHTHYRIDINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION AND THEIR USE AS MEDICINES
DK318486D0 (en)	1986-07-04	ANTHRACYCLIN-TETRASACCHARIDES, A PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS CYTOSTATICS
DK161647C (en)	1992-01-27	ISOXAZOLE OR ISOXAZOLINE-BETA CARBOLINE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THEM AND PROCEDURE FOR THEIR PREPARATION

Legal Events

Date	Code	Title	Description
1992-06-29	AHB	Application shelved due to non-payment